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Resumo
Cavalos de corrida são comumente afetados por uma condição denomidada Hemorraga Pulmonar Induzida por Esforço 
(HPIE), que consiste no rompimento das membranas alevolares e extravazamento de sangue para as vias aéreas. Considera-
se que a HPIE afeta negativamente o desempenho atlético dos cavalos de corrida e não há, atualmente, tratamento para 
a condição. Para reduzir a quantidade de sangramento, o diurético furosemida tem sido utilizado antes de exercício e 
competição em alguns hipódromos. A eficácia da furosemida em reduzir a HPIE foi documentada neste trabalho através 
da observação endoscópica das vias aéreas de equinos positivos para HPIE após duas corridas consecutivas.
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Abstract
Racehorses are commonly affected by a condition known as Exercise Induced Pulmonary Haemorrhage (EIPH) which 
consists of rupture of alveolar membranes and extravasation of blood into the airways. EIPH is considered to negatively 
affect racehorse performance and there is no current treatment. In order to reduce the amount of bleeding the diuretic 
furosemide has been used prior to exercise and competition in some racing jurisdictions. Efficacy of furosemide in 
reducing EIPH is documented in this research through endoscopic observation of the airways of horses positive for EIPH 
in two consecutive races.
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Introdução
Exercise Induced Pulmonary Haemorrhage is 
a condition affecting racehorses and other mammals 
subjected to running at high speeds. It is characterized 
by stress failure of alveolar capillaries1 with 
subsequent bleeding into the airways. Evaluation of 
EIPH is conducted mainly by respiratory endoscopy 
after exercise, with visualisation of blood in the 
trachea. Prophylaxis of Exercise Induced Pulmonary 
Haemorrhage (EIPH) with Furosemide (FUR) has 
become widespread, despite the fact that its results are 
questionable in efficiently and consistently controlling 
haemorrhage. In Brazil, Thoroughbred racehorses are 
entitled to the use of FUR once they are endoscopically 
diagnosed as EIPH positive by authorized veterinarians. 
A recent revision statement concerning EIPH has 
declared there is convincing scientific evidence that the 
condition is progressive and weak recommendations 
regarding the use of furosemide (FUR) as an effective 
way of managing EIPH2. This study evaluated the 
efficacy of first time FUR use under competition 
circumstances by comparing endoscopies after two 
consecutive races.
Material and Methods
Ethics approval was granted for conduction 
of this research (Wintec protocol 93) and informed 
consent from the people responsible for the horses was 
obtained. Thoroughbreds racing at Gavea Hippodrome 
(Rio de Janeiro, Brazil) from August to December 
2006, that displayed endoscopic signs of EIPH for the 
first time after a race (Group FUR, R1), were included 
in the study. EIPH grading (0-4) was according to the 
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literature3.  Horses in group FUR were then medicated 
with 4 ml of Furosemide (50 mg/ml) 4 hours prior to 
their next competition. All horses included in this group 
were under the professional care of two of the authors 
at the time of evaluation and the protocols used were 
part of the veterinary management of the treated group. 
A second endoscopy (Group FUR, R2) was performed 
up to 30 minutes after the end of this second race. The 
control group (Group CON) consisted of animals with 
endoscopies after two consecutive races but that were 
not medicated with furosemide and were chosen from 
the pool of matched horses racing during the same 
period of time as the FUR group. The study included 
intact males, females and geldings between 2.5 and 
6 years of age. There were 147 horses that met the 
selection criteria, however to eliminate confounding 
due to initial EIPH grade and to have both FUR and 
CON horses in each initial EIPH grade, 10 controls 
without initial EIPH were omitted. Fifteen FUR horses 
with an initial grade of 4 were also deleted due to lack 
of matched controls. The Mantel-Haenszel estimate 
of the risk ratio of a decrease in EIPH grade when 
comparing FUR and CON horses was calculated.
Results
A total of 96 animals were included in Group 
FUR and 26 were included in Group CON. Horses 
that received FUR had a higher chance (risk ratio 
2.1, 95%CI 1.2 to 3.8, P=0.0013) of presenting a 
subsequent lower degree of haemorrhage than horses 
not medicated. In Group FUR, 62 horses (64.6%)) 
displayed a decrease in EIPH grade after FUR; 29 
(30.2%) did not show any difference and 5 (5.2%) 
presented an increase between R1 and R2. In Group 
CON, 8 horses (30.8%) displayed a decreased grade 
of EIPH in the second endoscopy, while 9 (34.6%) did 
not show any difference and 9 (34.6%) presented an 
increase between the two endoscopies.
Discussion
Furosemide´s mode of action in controlling 
EIPH is still unclear but it has been demonstrated that 
is it efficient in reducing EIPH in racehorses4, 5. In the 
present study the efficacy of FUR in reducing EIPH 
in racehorses receiving the drug for the first time is 
documented. In comparison, EIPH positive horses 
not receiving furosemide showed either an increase 
or no change in bleeding grades in two consecutive 
endoscopies. It has been postulated that EIPH reduced 
athletic performance overtime6,7 and there is a welfare 
concern involving the occurrence of EIPH and the 
lack of treatment for the condition. Furosemide is the 
only approved pre-competition drug administered to 
EIPH positive racehorses in most racing jurisdictions 
making it essential that its mode of action and effects 
are studied in detail.  
Conclusions
FUR reduced at least one grade of EIPH in 64.6% 
of the Thoroughbreds using the drug for the first time 
in competition compared with 30.8% of control horses. 
Horses affected with EIPH had a significantly higher 
chance of subsequent reduced bleeding if medicated 
with furosemide than controls. 
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